Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Gastroenterology & Hepatology|August 3, 2016
Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameterEda Kaya, Dogac Demir, Yesim O Alahdab, et al.
Hepatology Communications|June 19, 2025
Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020Phuc Le, Eda Kaya, Anh Phan, et al.
European Journal of Gastroenterology & Hepatology|October 26, 2019
The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease studyFuad Jafarov, Eda Kaya, Alev Bakir, et al.
Digestive Diseases and Sciences|August 19, 2021
A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver DiseasePaul P Manka, Eda Kaya, Ali Canbay, et al.
Medicine|October 21, 2024
Estimation of the graft failure by current value joint model, and extension to alternative parameterization structures: Cohort studyAlev Bakir, Zeynep Atli, Eda Kaya, et al.
Acta Diabetologica|January 4, 2020
Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver diseaseTasnim Alkayyali, Lubna Qutranji, Eda Kaya, et al.
The Turkish Journal of Pediatrics|December 2, 2025
Trends and clinical features of childhood diabetes subgroups: 28 years of single center experienceİsmail Dündar, Ayşehan Akıncı, Emine Çamtosun, et al.
Hepatology Forum|August 11, 2022
The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patientsEmre Batuhan Kenger, Hakan Guveli, Can Ergun, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acidsHakan Guveli, Emre Batuhan Kenger, Tugce Ozlu, et al.
Advances in Kidney Disease and Health|September 1, 2023
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross TalkJacob Nysather, Eda Kaya, Paul Manka, et al.
Pageof 5